Dr. Peyman Zaman Samghabadi, MD

Dr. Samghabadi practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Samghabadi's NPI, 1295171908, was assigned on May 21, 2013. Dr. Samghabadi graduated from Renaissance School of Medicine at Stony Brook University in 2013. Dr. Samghabadi holds California license A132309.

Dr. Samghabadi's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Samghabadi's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Dr. Samghabadi is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Samghabadi to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samghabadi practices, 4 sites in all. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Samghabadi's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Samghabadi is board certified in cytopathology by the American Board of Pathology. Dr. Samghabadi is licensed in California.

CMS data shows 360 Medicare services from Dr. Samghabadi across 7 procedure codes in 2024, for 70 Medicare patients. Medicare paid $13,475 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Samghabadi in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samghabadi's median patient age at 65, with 50% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Samghabadi for performance year 2024, reported as part of a group. Dr. Samghabadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Samghabadi, published from 2019 to 2020. Dr. Samghabadi has published most often in Oncogene. Dr. Samghabadi's most frequent co-authors are Gordon Ho-Wan Li, MD, Robert Shigeo Ohgami, MD, PhD and Edward Douglas Plowey, MD, PhD.

CMS Open Payments shows 1 general payment to Dr. Samghabadi from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Foundation Medicine, Inc. paid the most, $12.

Dr. Samghabadi graduated from Renaissance School of Medicine at Stony Brook University in 2013.

Dr. Samghabadi is in network with 2 carriers, including Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.